Form 4 for PHR Phreesia, Inc.
Accepted 2022-09-20 00:00:00 ET · period of report 2022-09-16 · accession 0001562180-22-006763 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-09-20 | 2022-09-16+ | PHR | Linetsky David | SVP, Life Sciences | F - Tax | $27.70 | -49 | 5,648 | -0.9% | -$1,357 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-17 | F | D | 14 | $27.70 | 5,634 | I By spouse | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person or his spouse. |
| 2 | Common | Common Stock | 2022-09-16 | F | D | 35 | $27.70 | 5,648 | I By spouse | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person or his spouse. |